Treatment of Myelofibrosis: Old and New Strategies

por Iurlo, Alessandra, Cattaneo, Daniele
Publicado en Clin Med Insights Blood Disord (2017)

Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic Options

por Iurlo, Alessandra, Cattaneo, Daniele, Gianelli, Umberto
Publicado en Int J Mol Sci (2019)

New Perspectives on Polycythemia Vera: From Diagnosis to Therapy

por Iurlo, Alessandra, Cattaneo, Daniele, Bucelli, Cristina, Baldini, Luca
Publicado en Int J Mol Sci (2020)

Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic Challenge

por Iurlo, Alessandra, Cattaneo, Daniele, Bucelli, Cristina, Breccia, Massimo
Publicado en J Clin Med (2021)

Ponatinib as a Valid Alternative Strategy in Patients with Blast Crisis-Chronic Myeloid Leukemia Not Eligible for Allogeneic Stem Cells Transplantation and/or Conventional Chemothe...

por Bucelli, Cristina, Cattaneo, Daniele, Ferla, Valeria, Zappa, Manuela, de Benedittis, Caterina, Soverini, Simona, Iurlo, Alessandra
Publicado en Case Rep Hematol (2017)

Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase

por Breccia, Massimo, Abruzzese, Elisabetta, Iurlo, Alessandra, Gozzini, Antonella, Isidori, Alessandro, Gangemi, Domenica, Pregno, Patrizia, Alimena, Giuliana
Publicado en Haematologica (2016)

Imatinib and ruxolitinib association: first experience in two patients

por Iurlo, Alessandra, Gianelli, Umberto, Rapezzi, Davide, Cattaneo, Daniele, Fermo, Elisa, Binda, Francesca, Santambrogio, Elisa, Bucelli, Cristina, Cortelezzi, Agostino
Publicado 2014

Erdheim–Chester Disease With Multiorgan Involvement, Following Polycythemia Vera: A Case Report

por Iurlo, Alessandra, Dagna, Lorenzo, Cattaneo, Daniele, Orofino, Nicola, Bianchi, Paola, Cavalli, Giulio, Doglioni, Claudio, Gianelli, Umberto, Cortelezzi, Agostino
Publicado en Medicine (Baltimore) (2016)

The Role of New Technologies in Myeloproliferative Neoplasms

por Palumbo, Giuseppe A., Stella, Stefania, Pennisi, Maria Stella, Pirosa, Cristina, Fermo, Elisa, Fabris, Sonia, Cattaneo, Daniele, Iurlo, Alessandra
Publicado en Front Oncol (2019)

Current Strategies and Future Directions to Achieve Deep Molecular Response and Treatment-Free Remission in Chronic Myeloid Leukemia

por Annunziata, Mario, Bonifacio, Massimiliano, Breccia, Massimo, Castagnetti, Fausto, Gozzini, Antonella, Iurlo, Alessandra, Pregno, Patrizia, Stagno, Fabio, Specchia, Giorgina
Publicado en Front Oncol (2020)

An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature review

por Orofino, Nicola, Cattaneo, Daniele, Bucelli, Cristina, Pettine, Loredana, Fabris, Sonia, Gianelli, Umberto, Fracchiolla, Nicola Stefano, Cortelezzi, Agostino, Iurlo, Alessandra
Publicado en Leuk Res Rep (2017)

Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response

por Iurlo, Alessandra, Gianelli, Umberto, Beghini, Alessandro, Spinelli, Orietta, Orofino, Nicola, Lazzaroni, Francesca, Cambiaghi, Stefano, Intermesoli, Tamara, Rambaldi, Alessandro, Cortelezzi, Agostino
Publicado 2014

HHV8-Negative Effusion-Based Large B Cell Lymphoma Arising in Chronic Myeloid Leukemia Patients under Dasatinib Treatment: A Report of Two Cases

por Fiori, Stefano, Todisco, Elisabetta, Ramadan, Safaa, Gigli, Federica, Falco, Patrizia, Iurlo, Alessandra, Rampinelli, Cristiano, Croci, Giorgio, Pileri, Stefano A., Tarella, Corrado
Publicado en Biology (Basel) (2021)

Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality

por Fattizzo, Bruno, Giannotta, Juri Alessandro, Sciumè, Mariarita, Cattaneo, Daniele, Bucelli, Cristina, Fracchiolla, Nicola Stefano, Onida, Francesco, Baldini, Luca, Barcellini, Wilma, Iurlo, Alessandra
Publicado en Leukemia (2020)

Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem?

por Iurlo, Alessandra, Orsi, Emanuela, Cattaneo, Daniele, Resi, Veronica, Bucelli, Cristina, Orofino, Nicola, Sciumè, Mariarita, Elena, Chiara, Grancini, Valeria, Consonni, Dario, Orlandi, Ester Maria, Cortelezzi, Agostino
Publicado en Oncotarget (2015)

How many chronic myeloid leukemia patients who started a frontline second‐generation tyrosine kinase inhibitor have to switch to a second‐line treatment? A retrospective analysis f...

por Breccia, Massimo, Olimpieri, Pier Paolo, Olimpieri, Odoardo, Pane, Fabrizio, Iurlo, Alessandra, Foggi, Paolo, Cirilli, Alessia, Colatrella, Antonietta, Cuomo, Marcello, Gozzo, Lucia, Summa, Valentina, Corradini, Paolo, Russo, Pierluigi
Publicado en Cancer Med (2020)

Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease...

por Geyer, Julia T., Margolskee, Elizabeth, Krichevsky, Spencer A., Cattaneo, Daniele, Boiocchi, Leonardo, Ronchi, Paola, Lunghi, Francesca, Scandura, Joseph M., Ponzoni, Maurilio, Hasserjian, Robert P., Gianelli, Umberto, Iurlo, Alessandra, Orazi, Attilio
Publicado en Haematologica (2020)

How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy—a GIMEMA MPN WP survey

por Palandri, Francesca, Piciocchi, Alfonso, De Stefano, Valerio, Breccia, Massimo, Finazzi, Guido, Iurlo, Alessandra, Fazi, Paola, Soddu, Stefano, Martino, Bruno, Siragusa, Sergio, Albano, Francesco, Passamonti, Francesco, Vignetti, Marco, Vannucchi, Alessandro M.
Publicado en Leukemia (2020)

COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey

por Breccia, Massimo, Piciocchi, Alfonso, De Stefano, Valerio, Finazzi, Guido, Iurlo, Alessandra, Fazi, Paola, Soddu, Stefano, Martino, Bruno, Palandri, Francesca, Siragusa, Sergio, Albano, Francesco, Passamonti, Francesco, Vignetti, Marco, Vannucchi, Alessandro M.
Publicado en Leukemia (2020)

Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study

por Cattaneo, Daniele, Croci, Giorgio Alberto, Bucelli, Cristina, Tabano, Silvia, Cannone, Marta Giulia, Gaudioso, Gabriella, Barbanti, Maria Chiara, Barbullushi, Kordelia, Bianchi, Paola, Fermo, Elisa, Fabris, Sonia, Baldini, Luca, Gianelli, Umberto, Iurlo, Alessandra
Publicado en Front Oncol (2021)